BTP spends 53.6m on Hexachimie

27 May 1998

BTP spends £53.6m on Hexachimie

BTP, the speciality chemicals group, is buying Hexachimie, the fine chemical manufacturing arm of Bristol-Myers Squibb, for £53.6 million.

BTP wants to expand into the drug and agrochemical markets. BTP shares have soared recently after takeover speculation and publicity surrounding the new impotence pill Viagra. BTP supplies an ingredient in the Viagra pill which is made by Pfizer – the pharmaceuticals group.

  • The Times 27/05/98 page 25
  • The Daily Telegraph 27/05/98 page 35

See more